ScholarIQanswers from OpenAlex

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease

PaperCitations, authors & open-access status

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease have?

ScholarIQcitation count

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease has 388 citations in the OpenAlex counts ScholarIQ stores.

When was In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease published?

ScholarIQyear

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease has 2014 year in the ScholarIQ index.

What is the open-access status of In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease?

ScholarIQoa status

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease has green oa status in the ScholarIQ index.

What is the DOI of In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease?

ScholarIQdoi

The DOI for In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease is on the source record.

What is the PMID of In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease?

ScholarIQpmid

The PMID for In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease is on the source record.

What is the OpenAlex record for In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease?

ScholarIQopenalex

The OpenAlex for In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial